CoChat

B-cell-specific checkpoint molecules that regulate anti-tumour immunity

Open access
Bod, Lloyd, Kye, Yoon-Chul, Shi, Jingwen, Torlai Triglia, Elena, Schnell, Alexandra, Fessler, Johannes, Ostrowski, Stephen M., Von-Franque, Max Y., Kuchroo, Juhi R., Barilla, Rocky M., Zaghouani, Sarah, Christian, Elena, Delorey, Toni Marie, Mohib, Kanishka, Xiao, Sheng, Slingerland, Nadine, Giuliano, Christopher J., Ashenberg, Orr, Li, Zhaorong, Rothstein, David M., Fisher, David E., Rozenblatt-Rosen, Orit, Sharpe, Arlene H., Quintana, Francisco J., Apetoh, Lionel, Regev, Aviv, Kuchroo, Vijay K. · 2023 · Nature
Cited by 175

The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.

Abstract

The role of B cells in anti-tumour immunity is still debated and, accordingly, immunotherapies have focused on targeting T and natural killer cells to inhibit tumour growth^ 1 , 2 . Here, using high-throughput flow cytometry as well as bulk and single-cell RNA-sequencing and B-cell-receptor-sequencing analysis of B cells temporally during B16F10 melanoma growth, we identified a subset of B cells that expands specifically in the draining lymph node over time in tumour-bearing mice. The expanding B cell subset expresses the cell surface molecule T cell immunoglobulin and mucin domain 1 (TIM-1, encoded by Havcr1 ) and a unique transcriptional signature, including multiple co-inhibitory molecules such as PD-1, TIM-3, TIGIT and LAG-3. Although conditional deletion of these co-inhibitory molecules on B cells had little or no effect on tumour burden, selective deletion of Havcr1 in B cells both substantially inhibited tumour growth and enhanced effector T cell responses. Loss of TIM-1 enhanced the type 1 interferon response in B cells, which augmented B cell activation and increased antigen presentation and co-stimulation, resulting in increased expansion of tumour-specific effector T cells. Our results demonstrate that manipulation of TIM-1-expressing B cells enables engagement of the second arm of adaptive immunity to promote anti-tumour immunity and inhibit tumour growth. Manipulation of TIM-1-expressing B cells enables engagement of the second arm of adaptive immunity to promote anti-tumour immunity and inhibit tumour growth.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41586-023-06231-0

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 22 references

Metadata

Authors
Bod, L., Kye, Y.-C., Shi, J., Torlai Triglia, E., Schnell, A., Fessler, J., Ostrowski, S. M., Von-Franque, M. Y., Kuchroo, J. R., Barilla, R. M., Zaghouani, S., Christian, E., Delorey, T. M., Mohib, K., Xiao, S., Slingerland, N., Giuliano, C. J., Ashenberg, O., Li, Z., Rothstein, D. M., Fisher, D. E., Rozenblatt-Rosen, O., Sharpe, A. H., Quintana, F. J., Apetoh, L., Regev, A., & Kuchroo, V. K.
Venue
Nature
Published
2023-06-21
Volume
619
Issue
7969
Pages
348-356
ISSN
  • 0028-0836 (ISSN-L)
  • 1476-4687
OpenAlex
W4381481431
Cited by
175
References
22
FWCI
18.12
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: B-cell-specific checkpoint molecules that regulate anti-tumour immunity. https://app.cochat.ai/papers/10.1038/s41586-023-06231-0
The paper
Bod, L., Kye, Y.-C., Shi, J., Torlai Triglia, E., Schnell, A., Fessler, J., Ostrowski, S. M., Von-Franque, M. Y., Kuchroo, J. R., Barilla, R. M., Zaghouani, S., Christian, E., Delorey, T. M., Mohib, K., Xiao, S., Slingerland, N., Giuliano, C. J., Ashenberg, O., Li, Z., . . . Kuchroo, V. K. (2023). B-cell-specific checkpoint molecules that regulate anti-tumour immunity. Nature. https://doi.org/10.1038/s41586-023-06231-0

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.